|
JPS5638578B2
(https=)
*
|
1973-05-18 |
1981-09-08 |
|
|
|
CH642665A5
(en)
|
1979-02-08 |
1984-04-30 |
Rudolf Berchtold |
Process for the preparation of 1-(omega-carboxyalkyl)-2-alkyl- glycero-3-phosphatides
|
|
US4329302A
(en)
*
|
1980-06-27 |
1982-05-11 |
Board Of Regents, The University Of Texas System |
Synthetic phosphoglycerides possessing platelet activating properties
|
|
DE3307925A1
(de)
|
1983-03-05 |
1984-09-06 |
A. Nattermann & Cie GmbH, 5000 Köln |
Neue 0-acyl-alkandiol-phospholipide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4614796A
(en)
*
|
1983-03-25 |
1986-09-30 |
Nippon Shinyaku Co., Ltd. |
Liposome and method of manufacture therefor
|
|
JPS6041652A
(ja)
*
|
1983-08-13 |
1985-03-05 |
Morinaga Milk Ind Co Ltd |
Ν−カルボベンジルオキシ−Ｌ−グルタミン酸−γ−コリンエステル塩の製造法
|
|
JPS60100544A
(ja)
|
1983-11-08 |
1985-06-04 |
Ono Pharmaceut Co Ltd |
新規なグリセリン誘導体，その製造方法及びその誘導体を含有する薬剤
|
|
JPS60104066A
(ja)
|
1983-11-10 |
1985-06-08 |
Ono Pharmaceut Co Ltd |
グリセリン誘導体
|
|
AT383130B
(de)
|
1984-05-15 |
1987-05-25 |
Chemie Linz Ag |
Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
|
|
US4710579A
(en)
|
1984-11-09 |
1987-12-01 |
Takeda Chemical Industries, Ltd. |
2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
|
|
JPH0617307B2
(ja)
|
1984-11-09 |
1994-03-09 |
武田薬品工業株式会社 |
抗腫瘍剤
|
|
US4827011A
(en)
*
|
1984-12-10 |
1989-05-02 |
American Cyanamid Company |
Antihypertensive phosphate derivatives
|
|
JPS61246196A
(ja)
*
|
1985-04-22 |
1986-11-01 |
Fuji Kagaku Kogyo Kk |
５′−０−アシル−５−フルオロウリジン及びその製造方法
|
|
DE3663522D1
(en)
*
|
1985-11-29 |
1989-06-29 |
Takeda Chemical Industries Ltd |
Phospholipid derivatives, their production and use
|
|
US5061626A
(en)
|
1986-03-24 |
1991-10-29 |
University Of Sydney |
Antigenic anarogues of platelet activating factor
|
|
AU7285487A
(en)
*
|
1986-04-07 |
1987-11-09 |
Upjohn Company, The |
Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
|
|
JPS6294A
(ja)
|
1986-05-09 |
1987-01-06 |
Toyama Chem Co Ltd |
新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法
|
|
JPS6354386A
(ja)
|
1986-08-26 |
1988-03-08 |
Takeda Chem Ind Ltd |
リン脂質およびその用途
|
|
JPS63190859A
(ja)
*
|
1986-09-18 |
1988-08-08 |
Takeda Chem Ind Ltd |
グリセリン誘導体
|
|
JPS63135395A
(ja)
|
1986-11-28 |
1988-06-07 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JPS63188692A
(ja)
*
|
1987-01-29 |
1988-08-04 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体の製造方法
|
|
DE3807123A1
(de)
|
1988-03-04 |
1989-09-14 |
Boehringer Mannheim Gmbh |
Substrate fuer phospholipasen
|
|
JPH01258691A
(ja)
|
1988-04-06 |
1989-10-16 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JP2534894B2
(ja)
|
1988-06-24 |
1996-09-18 |
日本ケミファ株式会社 |
新規なグリセリン誘導体およびその誘導体を含有する血圧降下剤
|
|
JPH0248585A
(ja)
|
1988-08-10 |
1990-02-19 |
Nippon Oil & Fats Co Ltd |
リン脂質誘導体及びその製造方法
|
|
JPH03258740A
(ja)
|
1990-03-06 |
1991-11-19 |
Kao Corp |
液体油、その製造法及びこれを含有する化粧料
|
|
ES2019552A6
(es)
|
1990-04-11 |
1991-06-16 |
Menarini Lab |
Procedimiento para la preparacion de glicerofosfolipidos.
|
|
JP2869572B2
(ja)
|
1990-05-14 |
1999-03-10 |
和光純薬工業株式会社 |
ホスファチジルコリン誘導体の製造方法
|
|
US5561052A
(en)
*
|
1992-06-18 |
1996-10-01 |
Koike; Katsumasa |
Process for detecting oxidized lipids and process for forming oxidized lipids
|
|
FR2714382B1
(fr)
*
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
AU1751795A
(en)
|
1994-03-04 |
1995-09-18 |
University Of British Columbia, The |
Liposome compositions and methods for the treatment of atherosclerosis
|
|
JP3364313B2
(ja)
|
1994-03-22 |
2003-01-08 |
株式会社トクヤマ |
ポルフィリン／インジウム錯体及び陰イオン感応膜
|
|
EP0781138B1
(en)
|
1994-08-29 |
2008-05-21 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
JPH08208548A
(ja)
|
1995-02-01 |
1996-08-13 |
Kao Corp |
グリセリン誘導体の製造法
|
|
US5660855A
(en)
*
|
1995-02-10 |
1997-08-26 |
California Institute Of Technology |
Lipid constructs for targeting to vascular smooth muscle tissue
|
|
US6261597B1
(en)
*
|
1995-08-31 |
2001-07-17 |
Seymour J. Kurtz |
Method for treating periodontal disease
|
|
US6096291A
(en)
*
|
1996-12-27 |
2000-08-01 |
Biovector Therapeutics, S.A. |
Mucosal administration of substances to mammals
|
|
EP1001971A1
(en)
*
|
1997-07-31 |
2000-05-24 |
Elan Pharmaceuticals, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
JP3781877B2
(ja)
|
1997-10-03 |
2006-05-31 |
株式会社ムック |
アスコルビン酸誘導体またはその塩、および医薬
|
|
US6376450B1
(en)
|
1998-10-23 |
2002-04-23 |
Chanchal Kumar Ghosh |
Cleaning compositions containing multiply-substituted protease variants
|
|
US6414168B1
(en)
*
|
1998-12-28 |
2002-07-02 |
Caschem, Inc. |
Epoxidation of ricinic compounds using a phase-transfer catalyst
|
|
US6348583B1
(en)
|
1999-08-30 |
2002-02-19 |
Bio-Rad Laboratories, Inc. |
Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
|
|
DE60017787T2
(de)
|
1999-11-30 |
2006-01-05 |
ARIZONA BOARD OF REGENTS, on behalf of THE UNIVERSITY OF ARIZONA, Tucson |
Strahlung-sensitive liposomen
|
|
AU4976101A
(en)
|
2000-03-31 |
2001-10-15 |
Univ California |
Control of a gene induced by oxidized lipids in human artery wall cells
|
|
JP2002302470A
(ja)
*
|
2000-05-15 |
2002-10-18 |
Toagosei Co Ltd |
新規な第四アンモニウム塩及びその製造方法
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
AU1846102A
(en)
*
|
2000-11-24 |
2002-06-03 |
Cardimmune Ltd |
Methods employing and compositions containing defined oxidized phospholipids forprevention and treatment of atherosclerosis
|
|
FI20011466A0
(fi)
*
|
2001-07-04 |
2001-07-04 |
Orion Corp |
Prolyylioligopeptidaasia inhiboivaa aktiivisuutta omaavia yhdisteitä, niiden valmistusmenetelmiä ja käyttö
|
|
DE10155095A1
(de)
|
2001-11-09 |
2003-05-22 |
Cognis Deutschland Gmbh |
Alkyl(en)ylglycerinethercarbonsäuren
|
|
US7807847B2
(en)
|
2004-07-09 |
2010-10-05 |
Vascular Biogenics Ltd. |
Process for the preparation of oxidized phospholipids
|
|
CN103880876A
(zh)
*
|
2004-07-09 |
2014-06-25 |
脉管生物生长有限公司 |
制备氧化磷脂的改进方法
|
|
US20060194765A1
(en)
|
2004-11-16 |
2006-08-31 |
Garcia Joe G N |
Methods and compositions using oxidized phospholipids
|
|
WO2007014001A2
(en)
|
2005-07-21 |
2007-02-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Multiplex determination of lipid specific binding moieties
|
|
US8137977B2
(en)
|
2006-04-24 |
2012-03-20 |
Children's Hospital & Research Center At Oakland |
Lipidomic approaches to determining drug response phenotypes in cardiovascular disease
|
|
US8703179B2
(en)
|
2006-05-11 |
2014-04-22 |
Kimberly-Clark Worldwide, Inc. |
Mucosal formulation
|
|
JP2008037763A
(ja)
|
2006-08-01 |
2008-02-21 |
Adeka Corp |
抗菌剤及び抗菌剤組成物
|
|
US9006217B2
(en)
|
2007-01-09 |
2015-04-14 |
Vascular Biogenics Ltd. |
High-purity phospholipids
|
|
US20090149541A1
(en)
|
2007-11-28 |
2009-06-11 |
Yafit Stark |
Method of delaying the onset of clinically definite multiple sclerosis
|
|
US8999960B2
(en)
|
2008-10-08 |
2015-04-07 |
Vascular Biogenics Ltd. |
Oxidized thiophospholipid compounds and uses thereof
|
|
CN102271517B
(zh)
|
2008-11-06 |
2015-04-08 |
脉管生物生长有限公司 |
氧化的脂质化合物和其用途
|
|
JP2013516455A
(ja)
|
2010-01-05 |
2013-05-13 |
バスキュラー バイオジェニックス リミテッド |
Ｖｂ−２０１を用いた治療
|
|
SG11201400208PA
(en)
|
2011-09-01 |
2014-03-28 |
Vascular Biogenics Ltd |
Formulations and dosage forms of oxidized phospholipids
|